NCT06038708

Brief Summary

The purpose of this study is to explore changes in patients' hemodynamic parameters during the Head-Up Tilt Test ("HUTT") and their timing with respect to onset of the Closed Loop Stimulation (CLS) pacing. This study aims to add knowledge to better understand the mechanisms underlying recurrent syncopal events and optimal pacing programming.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Sep 2022

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 29, 2022

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 12, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 12, 2023

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 1, 2023

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 15, 2023

Completed
1.4 years until next milestone

Results Posted

Study results publicly available

February 3, 2025

Completed
Last Updated

February 3, 2025

Status Verified

October 1, 2024

Enrollment Period

8 months

First QC Date

September 1, 2023

Results QC Date

June 24, 2024

Last Update Submit

January 9, 2025

Conditions

Keywords

SyncopeHead-up Tilt TestClosed Loop StimulationCLS

Outcome Measures

Primary Outcomes (12)

  • Heart Rate [Bpm] at Specific Time-points During Head-up Tilt Test (HUTT) Examination

    Instantaneous measurement of heart rate value at specific time-points/stages during HUTT examination. Changes in Heart rate were investigated across four stages of the HUTT: baseline (Stage 1), pre-syncopal phase (Stage 2), maximum heart rate/pacing rate (Stage 3), and syncope or lowest Systolic Blood Pressure (Stage 4).

    From the start to the end of the HUTT examination, assessed up to 45 minutes

  • Systolic Blood Pressure at Specific Time-points During Head-up Tilt Test (HUTT) Examination

    Instantaneous measurement of blood pressure at specific time-points during HUTT examination. Changes in Systolic blood pressure were investigated across four stages of the HUTT: baseline (Stage 1), pre-syncopal phase (Stage 2), maximum heart rate/pacing rate (Stage 3), and syncope or lowest Systolic Blood Pressure (Stage 4).

    From the start to the end of the HUTT examination, assessed up to 45 minutes

  • Stroke Volume [ml] at Specific Time-points During Head-up Tilt Test (HUTT)

    Instantaneous measurement of stroke volume at specific time-points during HUTT examination

    From the start to the end of the HUTT examination, assessed up to 45 minutes

  • Peripheral Resistance [Dyn·s/cm5] at Specific Time-points During Head-up Tilt Test (HUTT)

    Instantaneous measurement of peripheral resistance at specific time-points during HUTT examination

    From the start to the end of the HUTT examination, assessed up to 45 minutes

  • Time of Maximum Spontaneous Heart Rate

    Recording of a specific time-point during HUTT examination. This time was collected as hours:minutes:seconds (e.g. 00:35:34).

    From the start to the end of the HUTT examination, assessed up to 45 minutes

  • Time of Pacing Onset

    Recording of a specific time-point during HUTT examination. This time was collected as hours:minutes:seconds (e.g. 00:35:34).

    From the start to the end of the HUTT examination, assessed up to 45 minutes

  • Time of Recovery of Spontaneous Rhythm After Pacing

    Recording of a specific time-point during HUTT examination. This time was collected as hours:minutes:seconds (e.g. 00:35:34).

    From the start to the end of the HUTT examination, assessed up to 45 minutes

  • Time of Syncope

    Recording of a specific time-point during HUTT examination. This time was collected as hours:minutes:seconds (e.g. 00:35:34).

    From the start to the end of the HUTT examination, assessed up to 45 minutes

  • Time of Tilt-down

    Recording of a specific time-point during HUTT examination. This time was collected as hours:minutes:seconds (e.g. 00:35:34).

    From the start to the end of the HUTT examination, assessed up to 45 minutes

  • Duration of the Recovery Phase [Minutes]

    Interval from maximum pacing rate to basic rate or spontaneous rhythm

    From the start to the end of the HUTT examination, assessed up to 45 minutes

  • Slope in Heart Rate [Bpm/Minute] During the Recovery Phase

    Calculation of the rate of change of heart rate from the time of maximum pacing rate to the time of basic rate or spontaneous rhythm recovery

    From the start to the end of the HUTT examination, assessed up to 45 minutes

  • Slope in Systolic Blood Pressure (mmHg Per Minute) During the Recovery Phase

    Calculation of the rate of change of systolic blood pressure from the time of maximum pacing rate to the time of basic rate or spontaneous rhythm recovery

    From the start to the end of the HUTT examination, assessed up to 45 minutes

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with reflex syncope and positive cardioinhibitory response to Head-Up Tilt Test (HUTT) who had already participated in the BIOSync study.

You may qualify if:

  • Ability to understand the nature of the study.
  • Willingness to provide written informed consent.
  • Patients undergoing HUTT for monitoring of syncope, therapy adjustment, training or other medical reasons during ordinary follow-up, irrespective of study participation
  • Patients who participated in the BIOSync study\*.

You may not qualify if:

  • Pregnant or breast feeding women.
  • Age less than 40 years.
  • Patients who after the BIOSync study participation have developed the following:
  • Any indication to pacemaker different from reflex syncope with positive HUTT response; or
  • Any classified indication to implantable defibrillator, cardiac resynchronization therapy according to current guidelines; or
  • Any cardiac dysfunctions likely leading to loss of consciousness (overt heart failure, ejection fraction \<40%, myocardial infarction, diagnosis of hypertrophic or dilated cardiomyopathy, clinically significant valvular disease, sinus bradycardia \<50 bpm or sinoatrial block, Mobitz I second degree atrioventricular block, Mobitz II second or third degree atrioventricular block, complete bundle-branch block).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Ospedale di Bolzano - Azienda Sanitaria dell'Alto Adige

Bolzano, 39100, Italy

Location

Monaldi - AORN dei Colli - Università della Campania "Luigi Vanvitelli"

Napoli, 80131, Italy

Location

Related Publications (1)

  • Russo V, Tomaino M, Parente E, Comune A, Giacopelli D, Napoli P, Gargaro A, Brignole M. Temporal relationship between haemodynamic changes and activation of closed-loop stimulation during a tilt-induced vasovagal syncope. Europace. 2024 Feb 1;26(2):euae045. doi: 10.1093/europace/euae045.

MeSH Terms

Conditions

SyncopeSyncope, Vasovagal

Condition Hierarchy (Ancestors)

UnconsciousnessConsciousness DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsOrthostatic IntolerancePrimary DysautonomiasAutonomic Nervous System Diseases

Results Point of Contact

Title
Paola Napoli, Clinical Project Manager
Organization
BIOTRONIK Italy

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Day
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 1, 2023

First Posted

September 15, 2023

Study Start

September 29, 2022

Primary Completion

May 12, 2023

Study Completion

May 12, 2023

Last Updated

February 3, 2025

Results First Posted

February 3, 2025

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will share

Data will be shared on request to the corresponding author with permission of BIOTRONIK SE \& Co. KG.

Shared Documents
STUDY PROTOCOL, SAP

Locations